Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2019-12-18 Capital/Financing Update
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제33회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, as it reports on the company's fundraising activity through debt instruments.
2019-12-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders eligible to vote at the 35th Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it is a specific regulatory disclosure regarding shareholder rights and meeting preparation, it fits best under the general regulatory filing category.
2019-12-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, conversion prices, put options, and the specific use of funds. This falls under the category of capital and financing updates as it describes a specific corporate financing activity.
2019-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a major shareholder's stake changes. It details the shareholding status of the largest shareholder (Jin Yang-gon) and special related parties, including changes due to a merger (HLB USA and LSK BioPartners). Since this is a specific regulatory disclosure regarding major shareholding thresholds and ownership changes, it falls under the 'Major Shareholding Notification' category.
2019-12-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in ownership, and collateral agreements of a major shareholder (Jin Yang-gon) in HLB Co., Ltd. It is a mandatory disclosure of significant share ownership (often referred to as a 5% report or major shareholding notification). Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2019-11-15 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for HLB Co., Ltd. covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, company overview, capital changes, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.